IT8723126A0 - Derivati dell'acido tiazolidin 4carbossilico ad attivita'farmaceutica. - Google Patents

Derivati dell'acido tiazolidin 4carbossilico ad attivita'farmaceutica.

Info

Publication number
IT8723126A0
IT8723126A0 IT8723126A IT2312687A IT8723126A0 IT 8723126 A0 IT8723126 A0 IT 8723126A0 IT 8723126 A IT8723126 A IT 8723126A IT 2312687 A IT2312687 A IT 2312687A IT 8723126 A0 IT8723126 A0 IT 8723126A0
Authority
IT
Italy
Prior art keywords
thiazolidin
derivatives
acid
pharmaceutical activity
pharmaceutical
Prior art date
Application number
IT8723126A
Other languages
English (en)
Other versions
IT1223565B (it
Inventor
Davide Della Bella
Angelo Carenzi
Dario Chiarino
Franco Pellacini
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Priority to IT23126/87A priority Critical patent/IT1223565B/it
Publication of IT8723126A0 publication Critical patent/IT8723126A0/it
Priority to ES88202956T priority patent/ES2059497T3/es
Priority to AT88202956T priority patent/ATE92053T1/de
Priority to EP88202956A priority patent/EP0322068B1/en
Priority to DE88202956T priority patent/DE3882682T2/de
Priority to US07/287,042 priority patent/US4952596A/en
Priority to JP63323214A priority patent/JP2856747B2/ja
Application granted granted Critical
Publication of IT1223565B publication Critical patent/IT1223565B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyrrole Compounds (AREA)
IT23126/87A 1987-12-21 1987-12-21 Derivati dell'acido tiazolidin 4 carbossilico ad attivita' farmaceutica IT1223565B (it)

Priority Applications (7)

Application Number Priority Date Filing Date Title
IT23126/87A IT1223565B (it) 1987-12-21 1987-12-21 Derivati dell'acido tiazolidin 4 carbossilico ad attivita' farmaceutica
ES88202956T ES2059497T3 (es) 1987-12-21 1988-12-19 Derivados del acido tiazolidin-4-carboxilico dotados de actividad farmacologica.
AT88202956T ATE92053T1 (de) 1987-12-21 1988-12-19 Thiazolidin-4-carbonsaeure-derivate mit pharmazeutischer wirkung.
EP88202956A EP0322068B1 (en) 1987-12-21 1988-12-19 Derivatives of thiazolidine-4-carboxylic acid having pharmacological activity
DE88202956T DE3882682T2 (de) 1987-12-21 1988-12-19 Thiazolidin-4-carbonsäure-Derivate mit pharmazeutischer Wirkung.
US07/287,042 US4952596A (en) 1987-12-21 1988-12-21 Derivatives of thiazolidine-4-carboxylic acid having pharmacological activity
JP63323214A JP2856747B2 (ja) 1987-12-21 1988-12-21 チアゾリジン‐４‐カルボン酸の誘導体、その製造方法及び該誘導体を有効成分とする医薬組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT23126/87A IT1223565B (it) 1987-12-21 1987-12-21 Derivati dell'acido tiazolidin 4 carbossilico ad attivita' farmaceutica

Publications (2)

Publication Number Publication Date
IT8723126A0 true IT8723126A0 (it) 1987-12-21
IT1223565B IT1223565B (it) 1990-09-19

Family

ID=11204066

Family Applications (1)

Application Number Title Priority Date Filing Date
IT23126/87A IT1223565B (it) 1987-12-21 1987-12-21 Derivati dell'acido tiazolidin 4 carbossilico ad attivita' farmaceutica

Country Status (7)

Country Link
US (1) US4952596A (it)
EP (1) EP0322068B1 (it)
JP (1) JP2856747B2 (it)
AT (1) ATE92053T1 (it)
DE (1) DE3882682T2 (it)
ES (1) ES2059497T3 (it)
IT (1) IT1223565B (it)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3818850A1 (de) * 1988-06-03 1989-12-07 Hoechst Ag Oligopeptide mit zyklischen prolin-analogen aminosaeuren
IT1230706B (it) * 1989-02-10 1991-10-29 Poli Ind Chimica Spa Derivati dell'acido 3 piroglutamoil tiazolidin 4 carbossilico e loro proprieta' farmacologiche.
NL9001955A (nl) * 1990-09-05 1992-04-01 Cedona Pharm Bv Nieuwe thiazolidinederivaten.
US5846988A (en) * 1996-03-25 1998-12-08 Alcon Laboratories, Inc. Thiazolidine-4-carboxylic acid derivatives as cytoprotective agents
US5756851A (en) * 1996-10-21 1998-05-26 Albemarle Corporation Production of nabumetone or precursors thereof
US5811425A (en) * 1997-03-04 1998-09-22 Abbott Laboratories Heterocyclic compounds as COX-2 inhibitors
DE69820614T2 (de) * 1997-05-30 2004-09-30 Celltech Therapeutics Ltd., Slough Entzündungshemmende tyrosin-derivate
US6329372B1 (en) 1998-01-27 2001-12-11 Celltech Therapeutics Limited Phenylalanine derivatives
JP2002504534A (ja) 1998-02-26 2002-02-12 セルテック・セラピューティクス・リミテッド α４インテグリンの阻害剤としてのフェニルアラニン誘導体
GB9805655D0 (en) 1998-03-16 1998-05-13 Celltech Therapeutics Ltd Chemical compounds
US6521626B1 (en) 1998-03-24 2003-02-18 Celltech R&D Limited Thiocarboxamide derivatives
GB9811159D0 (en) 1998-05-22 1998-07-22 Celltech Therapeutics Ltd Chemical compounds
GB9811969D0 (en) * 1998-06-03 1998-07-29 Celltech Therapeutics Ltd Chemical compounds
GB9814414D0 (en) 1998-07-03 1998-09-02 Celltech Therapeutics Ltd Chemical compounds
GB9821061D0 (en) 1998-09-28 1998-11-18 Celltech Therapeutics Ltd Chemical compounds
GB9821222D0 (en) 1998-09-30 1998-11-25 Celltech Therapeutics Ltd Chemical compounds
GB9825652D0 (en) 1998-11-23 1999-01-13 Celltech Therapeutics Ltd Chemical compounds
GB9826174D0 (en) 1998-11-30 1999-01-20 Celltech Therapeutics Ltd Chemical compounds
US6518283B1 (en) 1999-05-28 2003-02-11 Celltech R&D Limited Squaric acid derivatives
US6534513B1 (en) 1999-09-29 2003-03-18 Celltech R&D Limited Phenylalkanoic acid derivatives
US6455539B2 (en) 1999-12-23 2002-09-24 Celltech R&D Limited Squaric acid derivates
DE60130910T2 (de) 2000-04-17 2008-07-10 Ucb Pharma, S.A. Enamin-derivate als zell-adhäsionsmoleküle
US6545013B2 (en) 2000-05-30 2003-04-08 Celltech R&D Limited 2,7-naphthyridine derivatives
US6403608B1 (en) 2000-05-30 2002-06-11 Celltech R&D, Ltd. 3-Substituted isoquinolin-1-yl derivatives
EP1301488A1 (en) 2000-07-07 2003-04-16 Celltech R&D Limited Squaric acid derivatives containing a bicyclic heteroaromatic ring as integrin antagonists
JP2004505110A (ja) 2000-08-02 2004-02-19 セルテック　アール　アンド　ディ　リミテッド ３位置換イソキノリン−１−イル誘導体
CN102146062B (zh) * 2011-01-19 2013-04-24 山东大学 噻唑烷类神经氨酸酶抑制剂及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU195492B (en) * 1984-07-27 1988-05-30 Boehringer Biochemia Srl Process for producing 2-substituted thiazolidine derivatives with antitussive and mucus regulating action and pharmaceuticals comprising these compounds as active ingredient
HU200177B (en) * 1985-06-18 1990-04-28 Biogal Gyogyszergyar Process for producing thiazolidinecarboxylic acids and pharmaceutical compositions comprising such compounds
IT1196485B (it) * 1986-07-14 1988-11-16 Zambon Spa Derivati dell'acido tiazolidin-4-carbossilico ad attivita' farmaceutica

Also Published As

Publication number Publication date
US4952596A (en) 1990-08-28
IT1223565B (it) 1990-09-19
JP2856747B2 (ja) 1999-02-10
JPH01203373A (ja) 1989-08-16
DE3882682T2 (de) 1994-02-24
DE3882682D1 (de) 1993-09-02
ES2059497T3 (es) 1994-11-16
ATE92053T1 (de) 1993-08-15
EP0322068B1 (en) 1993-07-28
EP0322068A1 (en) 1989-06-28

Similar Documents

Publication Publication Date Title
IT8723126A0 (it) Derivati dell'acido tiazolidin 4carbossilico ad attivita'farmaceutica.
IT8621143A0 (it) Derivati dell'acido malonico e metodi per la loro sintesi.
IT8847794A0 (it) Derivati dell'acido furanuronico, loro preparazione e loro impiego come medicamenti
ITMI942156A0 (it) Derivati dell'acido p-amminopropionico ad attivita' fungicida
IT1230116B (it) Derivati dell'acido furanuronico, loro preparazione e loro impiego come medicamenti
IT8621112A0 (it) Derivati dell'acido tiazolidin-4-carbossilico adattivita' farmaceutica.
IT1167478B (it) Derivati dell'acido ursodesossicolico
IT1190400B (it) Derivati dell'acido 19,20-bis,nor-prostanoico ad attivita' antiulcera e anoressivca,procedimento per la loro preparazione e composizioni farmaceutiche
IT8321456A0 (it) Derivati dell'acido fenil-etil-acetico ad attivita'antiinfiammatoria.
IT8320236A0 (it) Derivato dell'acido tiolattico ad attivita'broncosecretogoga.
IT8224216A0 (it) Procedimento di preparazione di derivati dell'acido 2-pirrolacetico ad attivita' anti-infiammatoria.
IT1189209B (it) Derivati dell'acido cefalosporanico loro preparazione e loro applicazione come medicamenti
ITMI910581A1 (it) Derivati dell'acido 5-fenil-1h-pirazol-4-propionico, loro preparazione e loro impiego come medicamenti
IT8722693A0 (it) Sintesi elettrochimica dell'acido 2 metil 5 pirazinoico.
IT8422210A0 (it) Acido (2-osso-1-azetidinilossi)-2-propeno ico ad attivita' farmaceutica.
IT1184310B (it) Derivati dell'acido amminopropan-solfonico n-sostituiti
IT8620380A0 (it) Derivati dell'acido ottenoico.
IT1186693B (it) Derivati dell'acido cefalosporantico,loro preparazione e loro impiego come medicamenti
IT1213328B (it) Derivati dell'acido 2,2-dimetil-ciclopropancarbossilico .
IT8621934A0 (it) Procedimento per la preparazione di derivati salini dell'acido mercaptoetansolfonico.
IT8026521A0 (it) Derivati dell'acido carbotioico di mercaptoacilamminoacidi.
IT8847797A0 (it) Derivati dell' 1.3 -diossalano e dell'1.3-diossano e loro impiegocome medicamenti
IT8821135A0 (it) Derivato dell'acido ursodesossicolico.
IT8519731A0 (it) Derivato dell'acido propionidrossamico ad attivita'antiinfiammatoria ed antiartritica.
IT8119508A0 (it) Derivato dell'acido acetilsalicilico ad attivita'terapeutica, procedimento per lasua preparazione e relative composizioni farmaceutiche.

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19931124